A total of 35 percent of cancers diagnosed after second-opinion review were not initially detected in the original interpretation.
The Bach model, PLCOM2012, LCRAT, and LCDRAT most accurately predict risk and performed best in selecting ever-smokers for screening.
The drop in screening mammography after 2009 coincides with publication of the USPSTF screening guidelines.
False positives from stereotactic vacuum-assisted breast biopsies do not appear to dissuade women from continuing with regular screening afterward.
Targeted dose CT lung cancer screening does not have substantial effect on life-years saved among high risk groups.
Compared to standard biopsy strategy, MR imaging-guided strategies are cost effective in helping detect prostate cancer.
Routine thyroid cancer screening among asymptomatic patients does not offer any benefit for patients.
Screening for breast cancer among women at average risk still varies considerably between physicians.
Female Medicare beneficiaries with early-stage cancers do participate in screening mammogram programs.
Screening mammography is not utilized equally among racial groups.